We are live on ! Find out more
SAGE

Sage Therapeutics
SAGE

Delisted

SAGE was delisted on the 30th of July, 2025.

Back to rankings

248 hedge funds and large institutions have $4.65B invested in Sage Therapeutics in 2020 Q4 according to their latest regulatory filings, with 51 funds opening new positions, 74 increasing their positions, 85 reducing their positions, and 33 closing their positions.

New
Increased
Maintained
Reduced
Closed

55% more first-time investments, than exits

New positions opened: 51 | Existing positions closed: 33

43% more capital invested

Capital invested by funds: $3.26B → $4.65B (+$1.39B)

18% more call options, than puts

Call options by funds: $54.8M | Put options by funds: $46.6M

8% more funds holding

Funds holding: 230 → 248 (+18)

0.12% more ownership

Funds ownership: 103.25% → 103.37% (+0.12%)

0% more funds holding in top 10

Funds holding in top 10: 7 → 7 (0)

13% less repeat investments, than reductions

Existing positions increased: 74 | Existing positions reduced: 85

Holders
248
Holders Change
+18
Holders Change %
+7.83%
% of All Funds
4.39%
Holding in Top 10
7
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.12%
New
51
Increased
74
Reduced
85
Closed
33
Calls
$54.8M
Puts
$46.6M
Net Calls
+$8.17M
Net Calls Change
-$24.4M

Top Buyers

1
Wellington Management Group
Wellington Management Group
Massachusetts
+$298M
2
Deutsche Bank
Deutsche Bank
Germany
+$32.5M
3
PA
Perceptive Advisors
New York
+$32.4M
4
Janus Henderson Group
Janus Henderson Group
United Kingdom
+$26.5M
5
MWNA
Marshall Wace North America
New York
+$22.1M

Top Sellers

1
GPP
Great Point Partners
Connecticut
-$111M
2
Citadel Advisors
Citadel Advisors
Florida
-$68.2M
3
Adage Capital Partners
Adage Capital Partners
Massachusetts
-$36.9M
4
BCLSI
Bain Capital Life Sciences Investors
Massachusetts
-$30.5M
5
Victory Capital Management
Victory Capital Management
Texas
-$25.3M
Name Holding Trade Value Shares
Change 		Change in
Stake
PA
26
Perceptive Advisors
New York
$38.1M +$32.4M +440,000 New
Two Sigma Advisers
27
Two Sigma Advisers
New York
$36.5M -$8.08M -109,600 -21%
UBS AM
28
UBS AM
Illinois
$35.4M -$2.7M -36,575 -8%
AG
29
Artal Group
Luxembourg
$34.6M +$13.1M +177,700 +80%
Ameriprise
30
Ameriprise
Minnesota
$33.7M -$26.7K -362 -0.1%
Westfield Capital Management
31
Westfield Capital Management
Massachusetts
$30.6M -$14.9M -201,870 -36%
NNPTE
32
Nationale-Nederlanden Powszechne Towarzystwo Emerytalne
Poland
$27.2M +$113K +1,536 +0.5%
DKCM
33
Davidson Kempner Capital Management
New York
$26.6M +$16.3M +220,600 +252%
Northern Trust
34
Northern Trust
Illinois
$25.2M -$561K -7,607 -3%
Charles Schwab
35
Charles Schwab
California
$22.4M +$255K +3,460 +1%
Manulife (Manufacturers Life Insurance)
36
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$22.3M -$4.11M -55,741 -18%
ACP
37
Acuta Capital Partners
California
$22.1M +$2.27M +30,800 +14%
Franklin Resources
38
Franklin Resources
California
$21.7M +$4.35K +59 +0%
Jacobs Levy Equity Management
39
Jacobs Levy Equity Management
New Jersey
$20.3M -$1.76M -23,880 -9%
N
40
Nuveen
North Carolina
$19.2M -$2.32M -31,451 -12%
AAMU
41
Amundi Asset Management US
Massachusetts
$18.1M -$1.01M -13,731 -6%
American Century Companies
42
American Century Companies
Missouri
$18M -$873K -11,845 -5%
GLA
43
Great Lakes Advisors
Illinois
$18M +$15.3M +207,692 New
Bank of New York Mellon
44
Bank of New York Mellon
New York
$17.9M +$258K +3,497 +2%
PPA
45
Parametric Portfolio Associates
Washington
$17.8M +$1.97M +26,695 +15%
IHAM
46
Integral Health Asset Management
New York
$16.9M -$2.58M -35,000 -15%
Dimensional Fund Advisors
47
Dimensional Fund Advisors
Texas
$16.8M -$970K -13,156 -6%
WP
48
Woodline Partners
California
$16M -$42.5K -576 -0.3%
ACM
49
Asymmetry Capital Management
California
$15.7M +$5.84M +79,188 +77%
DCM
50
DAFNA Capital Management
California
$15.7M +$1.7M +23,000 +15%
1
2
3 4 5

SAGE Hedge Fund Activity: Q4 2020 in Review

248 of the 5,651 institutional investors tracked by Wall St. Rank reported a position in Sage Therapeutics (SAGE) for Q4 2020, worth a combined $4.65B — up 43% from $3.26B a quarter earlier.

Buyers outnumbered sellers: 51 funds opened new SAGE positions and 33 closed out — a net gain of 18 holders — while 74 added to existing stakes and 85 trimmed.

The largest buyer was Wellington Management Group, adding an estimated $298M. The largest seller was Great Point Partners, cutting an estimated $111M.

  • 248 institutional investors held Sage Therapeutics (SAGE) as of Q4 2020, up from 230 in Q3 2020.
  • Funds reported $4.65B of Sage Therapeutics stock for Q4 2020, up 43% quarter-over-quarter.
  • 51 funds opened new Sage Therapeutics positions in Q4 2020 and 33 closed out, a net change of +18 holders.
  • The largest Sage Therapeutics buyer in Q4 2020 was Wellington Management Group, an estimated $298M added.
  • The largest Sage Therapeutics seller in Q4 2020 was Great Point Partners, an estimated $111M sold.

Based on aggregated 13F filings for Q4 2020.